← Science Applications International Corp
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.5b | $4.5b | $4.7b | $6.4b | $7.1b | $7.4b | $7.7b | $7.4b | $7.5b | $7.3b | |
| Cost of Revenue | $4.0b | $4.0b | $4.2b | $5.7b | $6.3b | $6.5b | $6.8b | $6.6b | $6.6b | $6.4b | |
| Gross Profit (Calculated) | $447.0m | $411.0m | $464.0m | $706.0m | $792.0m | $859.0m | $888.0m | $872.0m | $892.0m | $872.0m | |
| Operating expenses: | |||||||||||
| Operating Income (Loss) | $271.0m | $256.0m | $220.0m | $370.0m | $390.0m | $462.0m | $501.0m | $741.0m | $563.0m | $521.0m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $26.0m | $21.0m | $24.0m | $95.0m | $147.0m | $128.0m | $125.0m | $115.0m | $115.0m | $119.0m | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Lease, Lease Income | — | — | — | — | $40.0m | $18.0m | $2.0m | $0 | $2.0m | — | |
| Other Operating Income | $271.0m | $256.0m | $220.0m | $370.0m | $390.0m | $462.0m | $501.0m | $741.0m | $4.6b | $521.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $220.0m | $214.0m | $170.0m | $286.0m | $271.0m | $358.0m | $375.0m | $620.0m | $428.0m | $387.0m | |
| Net Income (Loss) Attributable to Parent | $148.0m | $179.0m | $137.0m | $226.0m | $209.0m | $277.0m | $300.0m | $477.0m | $362.0m | $358.0m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | $0 | $3.0m | $2.0m | $2.0m | $3.0m | $0 | $0 | — | |
| Earnings Per Share, Basic | $3.33 | $4.13 | $3.16 | $3.87 | $3.60 | $4.81 | $5.42 | $8.98 | $7.23 | $7.73 | |
| Earnings Per Share, Diluted | $3.22 | $4.02 | $3.11 | $3.83 | $3.56 | $4.77 | $5.38 | $8.88 | $7.17 | $7.70 | |
| Common Stock, Dividends, Per Share, Declared | $1.24 | $1.24 | $1.24 | $1.48 | $0.37 | $0.37 | $0.37 | $0.37 | $0.37 | $0.37 | |
| Weighted Average Number of Shares Outstanding, Basic | 44.5m | 43.3m | 43.4m | 58.4m | 58.1m | 57.6m | 55.3m | 53.1m | 50.1m | 46.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 45.9m | 44.5m | 44.1m | 59.0m | 58.7m | 58.1m | 55.8m | 53.7m | 50.5m | 46.5m | |
| Research and Development Expense | $4.0m | $4.0m | $5.0m | $7.0m | $6.0m | $4.0m | $1.0m | $4.0m | $12.0m | $13.0m | |
| Selling, General and Administrative Expense | $166.0m | $155.0m | $158.0m | $288.0m | $352.0m | $344.0m | $374.0m | $373.0m | $339.0m | $350.0m | |
| Other Nonoperating Income (Expense) | $1.0m | $2.0m | $3.0m | $6.0m | $3.0m | $1.0m | ($6.0m) | ($1.0m) | ($9.0m) | ($6.0m) | |
| Business Combination, Acquisition Related Costs | — | — | — | $2.0m | $20.0m | $3.0m | ($2.0m) | $0 | ($2.0m) | — | |
| Interest Expense | $52.0m | $44.0m | $53.0m | $90.0m | $122.0m | $105.0m | $120.0m | — | — | — | |
| Interest Expense Operating | — | — | — | — | — | — | — | — | — | $128.0m | |
| Labor and Related Expense | — | — | — | — | — | — | — | — | $2.1b | $2.1b | |
| Restructuring and Related Cost, Incurred Cost | — | — | — | — | — | — | — | — | — | $22.0m | |
| Restructuring Costs | — | — | — | $16.0m | $10.0m | $1.0m | $20.0m | $23.0m | $8.0m | $12.0m | |
| Income Tax Expense (Benefit) | $72.0m | $35.0m | $33.0m | $57.0m | $60.0m | $79.0m | $72.0m | $143.0m | $66.0m | $29.0m | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | — | — | — | $1.0m | — | — | — | — | — | |
| Interest Income (Expense), Net | — | — | — | — | — | — | — | ($120.0m) | ($126.0m) | — | |
| Other Operating Income (Expense), Net | $271.0m | $256.0m | $220.0m | $370.0m | ($4.0m) | $3.0m | $0 | $3.0m | $10.0m | ($1.0m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.